If you haven't noticed, Denver is about to host the Democratic National Convention. And that means lots of parties. Recently Denver Post columnist Bill Husted reported Denver convention organizer, lobbyist Steve Farber, saying...
The rate of mergers and acquisitions among drugmakers has reached a feverish pace lately, but I can't see it slowing down anytime soon. If a company has multiple partnerships, like Biogen Idec (Nasdaq: BIIB), the joint ventures...
CAMBRIDGE, Mass. (AP) - Biotechnology company Alkermes Inc. said Thursday its fiscal 2009 first-quarter profit surged more than threefold on a payment from former partner Eli Lilly & Co. For the quarter ended June 30, Alkermes...
today announced its financial results for the three and six months ended June 30, 2008. For the three months ended June 30, 2008, the Company posted revenues of $4.3 million and a net loss of $7.2 million. Merger Agreement with...
By Rasmus Jorgensen and Kim McLaughlin COPENHAGEN, Aug 7 (Reuters) - Danish drug maker Novo Nordisk (NOVOb.CO: ) posted first-half earnings in line with market expectations on Thursday and raised its 2008 outlook, but the...
By DAMIAN TROISE and TOM MURPHY, AP INDIANAPOLIS--Drug-development services company Covance Inc. will buy an Indiana research center from Eli Lilly and Co. and enter a 10-year service deal with the drug maker worth $1.6...
Published: Aug. 6, 2008 at 3:19 PM INDIANAPOLIS, Aug. 6 (UPI) -- Eli Lilly and Co. said it has reached an agreement to sell its Greenfield Laboratories in New Jersey to Covance Inc. for $50 million. In the deal, Lilly said it...
WALTHAM, Mass. --(Business Wire)-- Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced a multi-year extension agreement with Eli Lilly and Company...
Wednesday August 6, 9:00 am ET Lilly to Lease New Elanco Global Headquarters in Hancock County, Indiana R&D restructuring aimed at increasing productivity and reducing drug development costs; U.S. clinical trial monitoring work...
By JOSEPH TARTAKOFF P-I REPORTER In a major boost to Seattle's biotech community, which this year alone has seen more than 280 workers lose their jobs, Danish drug giant Novo Nordisk is opening a research site here. By 2010,...